## NUE: Nucor Corporation - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_10 -1.1% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($156.80)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Buffett-Style Spotlight on Nucorâ€™s Infrastructure Role Might Change The Case For Investing In Nucor (NUE)**
- Source: Simply Wall Street | 20260106T162813 | Somewhat-Bullish | Relevance: 100%
- Nucor, a steel producer, is gaining investor attention due to its alignment with Warren Buffett's investment principles and potential benefits from U.S. infrastructure spending. While demand sensitivity and project execution remain key risks, a recent dividend increase showcases management's confidence. The article discusses various fair value estimates and encourages investors to develop their own narratives before making investment decisions.

**2. Wells Fargo Sees Pricing Recovery and Market Share Gains for Nucor (NUE)**
- Source: Insider Monkey | 20260107T154500 | Bullish | Relevance: 100%
- Wells Fargo analyst Timna Tanners maintains an Overweight rating on Nucor Corporation (NUE) despite lowering its price target to $176 from $178. The firm anticipates future pricing recovery and market share gains for Nucor, supported by lower imports and a new construction cycle driven by data centers and large industrial projects like Eli Lilly's new manufacturing plants. Nucor, as North America's largest steel producer, is well-positioned to benefit from these trends and is expanding capacity with a new mill in West Virginia.

**3. United States Metals & Mining Industry Report 2025, Profiles of Freeport-McMoRan, Newmont, Nucor, Peabody Energy**
- Source: Yahoo Finance | 20260105T155500 | Neutral | Relevance: 71%
- A new report highlights the United States metals and mining industry, detailing its market size, growth prospects, and competitive dynamics. Despite a recent decline in production volume, the industry, which includes aluminum, steel, and precious metals, recorded revenues of $146.14 billion in 2024, showing moderate growth. The report profiles key players like Freeport-McMoRan, Newmont, Nucor, and Peabody Energy, offering insights into their financial performance and strategies for strategic expansion.

**4. 14 Best Dividend Growth Stocks to Buy and Hold in 2026**
- Source: Insider Monkey | 20260106T172100 | Somewhat-Bullish | Relevance: 65%
- This article, part of a larger list, highlights Cintas Corporation (NASDAQ: CTAS) as a top dividend growth stock. It details Cintas's recent attempt to acquire UniFirst Corp. for approximately $3.96 billion, marking their third bid. Despite a "Sell" rating from Citi, Cintas is considered a strong investment due to its consistent dividend growth and strategic expansion efforts.

**5. 14 Best Dividend Growth Stocks to Buy and Hold in 2026**
- Source: Insider Monkey | 20260106T172100 | Somewhat-Bullish | Relevance: 65%
- This article, part of a larger list, highlights West Pharmaceutical Services, Inc. (NYSE: WST) as a top dividend growth stock for 2026. It discusses the company's strong performance driven by demand for components in GLP-1 weight-loss and diabetes drugs, increased full-year profit forecasts, and its position as a key supplier for essential medical components. Despite cautious market penetration estimates for oral GLP-1 drugs, injectable formats are expected to drive growth, benefiting WST.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | Wells Fargo | $176 | $178 | -1% |
| 2025-12-15 | Wells Fargo | $178 | $167 | +7% |
| 2025-12-10 | Jefferies | $190 | $170 | +12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | Wells Fargo | main | Overweight |
| 2025-12-15 | Wells Fargo | main | Overweight |
| 2025-12-10 | Jefferies | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 8 ($4.22M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 7 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (-3.1%)
- State Farm Mutual Au: 10.6% (-0.7%)
- Blackrock Inc.: 8.1% (-3.6%)
- State Street Corpora: 5.3% (-2.7%)
- Berkshire Hathaway, : 2.8% (-3.1%)

### Key Risks

1. High beta (1.88) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Momentum deterioration: MRS_10 falling (-1.8% 5d) with bearish MACD, trend may be turning.
3. Insider selling cluster: $4.2M in recent transactions.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.75 indicates undervaluation relative to growth. Forward P/E 14.0x attractive for 49% earnings growth. Balance sheet: strong liquidity (2.8x). Analyst sentiment positive (2 raises, avg +9%, $189 target (+14%)). Insider selling cluster ($4.2M in 90 days), potential headwind. Institutional flow bullish (2 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $37.7B |
| Beta | 1.88 |
| 52W Range | $97.59 - $171.94 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.75 |
| Forward P/E | 14.0 |
| Current P/E | 20.9 |
| YoY Growth | 49.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 0.7% to -1.1% (-1.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.1pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 55. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -1.07% (CS: 37) | Neutral |
| RSI_14 | 54.7 | Neutral |
| MACD Histogram | -0.18 | Bearish |
| vs SMA20 | 1.005x | Above |
| vs SMA50 | 1.053x | Above |
| vs SMA200 | 1.206x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $164.84
- **Stop Loss:** $156.80 (4.9% risk)
- **Target:** $172.88 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 93
- **Position Value:** $15,330.12
- **Portfolio %:** 15.33%
- **Risk Dollars:** $750.00
- **Risk Per Trade:** 0.75%
- **Modifiers:** L1 100% | L2 75% | Combined 0.75x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with balanced risk appetite. VIX at 15.38 sits in the normal range (18th percentile of 52-week) with modest upward drift, while yield curve remains positively sloped (+62bps 10Y-3M) supporting risk assets. Breadth at 59.5% shows healthy participation, though elevated put/call ratio (1.12) suggests some hedging activity. FOMC 20 days out provides runway for current conditions to persist.*

### Earnings

**Next:** 2026-01-26 (Est: $2.09)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.16 | $2.63 | +22.0% |
| 2025Q2 | $2.61 | $2.60 | -0.6% |
| 2025Q1 | $0.61 | $0.67 | +9.8% |
| 2024Q4 | $0.64 | $1.22 | +90.6% |

---
*RULE-based L3 | 2026-01-08 08:02 | MRS_10*